X4 Pharmaceuticals, Inc.
Compositions of CXCR4 inhibitors and methods of preparation and use
Last updated:
Abstract:
The present invention provides compositions and methods of use for treating, preventing, or ameliorating a disease, disorder, or condition associated with a chemokine receptor such as CXCR4.
Status:
Grant
Type:
Utility
Filling date:
5 Dec 2019
Issue date:
29 Jun 2021